Insider Buying: ASP Isotopes Inc. (NASDAQ:ASPI) Major Shareholder Acquires 70,000 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) major shareholder Ak Jensen Investment Managemen bought 70,000 shares of the company’s stock in a transaction on Monday, July 8th. The stock was bought at an average price of $3.05 per share, for a total transaction of $213,500.00. Following the completion of the purchase, the insider now directly owns 6,586,874 shares in the company, valued at $20,089,965.70. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Ak Jensen Investment Managemen also recently made the following trade(s):

  • On Wednesday, July 10th, Ak Jensen Investment Managemen acquired 61,849 shares of ASP Isotopes stock. The stock was purchased at an average cost of $3.40 per share, for a total transaction of $210,286.60.

ASP Isotopes Stock Up 14.9 %

Shares of NASDAQ:ASPI traded up $0.46 during trading hours on Wednesday, hitting $3.54. The company’s stock had a trading volume of 1,162,705 shares, compared to its average volume of 739,278. The company has a debt-to-equity ratio of 1.70, a current ratio of 3.57 and a quick ratio of 3.57. The firm’s fifty day moving average price is $3.97 and its 200 day moving average price is $3.39. ASP Isotopes Inc. has a 52 week low of $0.57 and a 52 week high of $5.67. The company has a market capitalization of $183.23 million, a price-to-earnings ratio of -6.17 and a beta of 5.12.

ASP Isotopes (NASDAQ:ASPIGet Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.16) earnings per share for the quarter. The business had revenue of $0.84 million during the quarter. As a group, research analysts expect that ASP Isotopes Inc. will post -0.11 EPS for the current year.

Institutional Investors Weigh In On ASP Isotopes

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after purchasing an additional 844,705 shares in the last quarter. Rathbones Group PLC purchased a new position in shares of ASP Isotopes in the 4th quarter worth approximately $272,000. HTLF Bank bought a new position in shares of ASP Isotopes during the 4th quarter worth approximately $141,000. Finally, Virtu Financial LLC lifted its position in ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after acquiring an additional 69,176 shares during the last quarter. Institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

Separately, HC Wainwright increased their price target on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a research report on Wednesday, April 17th.

View Our Latest Analysis on ASPI

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with's FREE daily email newsletter.